Home › Companies › REVOLUTION MEDICINES INC. › 2023-2024

REVOLUTION MEDICINES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and REVOLUTION MEDICINES INC.’s Form 8-K, filed 2024-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.

9Reported items
243Asset managers
2,096Fund votes
2024-06-20Main meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REVOLUTION MEDICINES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by REVOLUTION MEDICINES INC.

These tallies are REVOLUTION MEDICINES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REVOLUTION MEDICINES INC. — official shareholder meeting results, meeting held 2024-06-20
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Elizabeth McKee Anderson	107,146,109	--	--	23,367,071	17,669,340	Majority: yes
Elect Director: Flavia Borellini, Ph.D.	107,339,633	--	--	23,173,547	17,669,340	Majority: yes
Elect Director: Lorence Kim, M.D.	97,387,991	--	--	33,125,189	17,669,340	Majority: yes
Proposal 2 . The Company's stockholders ratified the appointment, by the audit committee of the Company's board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal y	148,105,275	9,895	67,350	--	--	Majority: yes
As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal. Proposal 3 .	128,861,403	1,624,748	27,029	--	17,669,340	Majority: yes

This meeting is also recorded here as 2024-06-19; both records come from the same filing, so the date should be checked against it.

Source: REVOLUTION MEDICINES INC., Form 8-K, filed with the SEC on 2024-06-24 — read the filing on EDGAR.

How asset managers voted at the REVOLUTION MEDICINES INC. 2023-2024 meetings

Each item below shows how the 243 asset managers that disclosed a REVOLUTION MEDICINES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REVOLUTION MEDICINES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION ("SAY-ON-PAY").

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-06-20.

Combines 8 wordings of this item as funds reported it.

99.2% fund support · no official result

FOR 99.2%

The 231 asset managers below cast 99.2% of the shares they voted on this item FOR (153,368,870 for, 1,110,783 against).

FOR: 153,368,870 (99.3%)AGAINST: 1,110,783 (0.7%)ABSTAIN: 13,388 (0.0%)

Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DI” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	22,564,962	0	For
New York Life	17,066,644	0	For
Wellington	13,261,836	0	For
BlackRock	11,220,982	16,257	For
Fidelity	10,010,910	0	For
T. Rowe Price	8,503,101	0	For
State Street	7,248,940	1,103	For
BVF INC/IL	5,981,212	0	For
Nextech Invest Ltd.	5,761,628	0	For
FARALLON CAPITAL MANAGEMENT LLC	5,087,354	0	For
Janus Henderson	4,209,071	0	For
Woodline Partners LP	3,399,131	0	For
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	3,090,073	0	For
GEODE CAPITAL MANAGEMENT, LLC	3,051,710	0	For
JPMorgan	2,244,856	0	For
JANUS INVESTMENT FUND	2,192,696	0	For
AH Capital Management, L.L.C.	2,128,523	0	For
Charles Schwab	2,115,720	0	For
Holocene Advisors, LP	1,258,003	0	For
Victory Capital	1,209,236	0	For
Northern Trust	1,169,161	99	For
Soleus Capital Management, L.P.	1,135,800	0	For
AMERIPRISE FINANCIAL INC	991,479	0	For
Dimensional	989,177	0	For
MARSHALL WACE, LLP	958,014	0	For

Showing the 25 largest of 231 asset managers. See all 231 in the interactive database.

2. To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Flavia Borellini, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 107,339,633WITHHELD: 23,173,547

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Flavia Borellini, Ph.D.”): 107,339,633 for, 23,173,547 withheld, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 164,913,014 outstanding shares: 65% for, 14% withheld (79% of the company cast a for/withheld vote).

The 70 asset managers below cast 99.9% of the shares they voted on this item FOR (44,383,531 for, 62 against).

FOR 83%ABSTAIN 17%

FOR: 44,383,531 (83.2%)AGAINST: 62 (0.0%)ABSTAIN: 8,945,192 (16.8%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	22,232,107	0	For
BlackRock	6,608,389	0	For
Fidelity	5,792,108	1,400	For
T. Rowe Price	0	3,734,343	Abstain
State Street	2,349,129	3,240	For
JANUS INVESTMENT FUND	0	2,192,696	Abstain
JPMorgan	2,096,349	0	For
Charles Schwab	1,057,860	0	For
Dimensional	0	826,675	Abstain
Hartford	758,858	0	For
Columbia Threadneedle	708,697	0	For
MUTUAL FUND SERIES TRUST	650,826	0	For
Victory Capital	2,257	459,383	Abstain
Equitable	214,272	174,336	For
TIAA	363,923	0	For
AIG/SunAmerica	0	263,509	Abstain
QUANTITATIVE MASTER SERIES LLC	260,003	0	For
Bridge Builder Trust	34,475	186,843	Abstain
John Hancock	88,806	111,039	Abstain
Direxion Shares ETF Trust	0	183,868	Abstain
Voya	164,067	0	For
Northwestern Mutual	152,888	0	For
Lincoln Financial	135,547	5,214	For
Jackson National	0	120,029	Abstain
ALPS ETF Trust	0	115,256	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

3. To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Lorence Kim, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD 25%

FOR: 97,387,991WITHHELD: 33,125,189

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Lorence Kim, M.D.”): 97,387,991 for, 33,125,189 withheld, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 164,913,014 outstanding shares: 59% for, 20% withheld (79% of the company cast a for/withheld vote).

The 70 asset managers below cast 99.9% of the shares they voted on this item FOR (38,833,073 for, 62 against).

FOR 73%ABSTAIN 27%

FOR: 38,833,073 (72.8%)AGAINST: 62 (0.0%)ABSTAIN: 14,495,650 (27.2%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	22,232,107	0	For
BlackRock	6,608,389	0	For
Fidelity	2,924,694	2,868,814	For
T. Rowe Price	0	3,734,343	Abstain
State Street	2,436	2,349,933	Abstain
JANUS INVESTMENT FUND	0	2,192,696	Abstain
JPMorgan	2,096,349	0	For
Charles Schwab	1,057,860	0	For
Dimensional	0	826,675	Abstain
Hartford	758,858	0	For
Columbia Threadneedle	708,697	0	For
MUTUAL FUND SERIES TRUST	650,826	0	For
Victory Capital	2,257	459,383	Abstain
Equitable	214,272	174,336	For
TIAA	363,923	0	For
AIG/SunAmerica	0	263,509	Abstain
QUANTITATIVE MASTER SERIES LLC	260,003	0	For
Bridge Builder Trust	34,475	186,843	Abstain
John Hancock	88,806	111,039	Abstain
Direxion Shares ETF Trust	0	183,868	Abstain
Voya	0	164,067	Abstain
Northwestern Mutual	152,888	0	For
Lincoln Financial	21,435	119,326	Abstain
Jackson National	0	120,029	Abstain
ALPS ETF Trust	0	115,256	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

4. To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Elizabeth McKee Anderson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 3 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 107,146,109WITHHELD: 23,367,071

REVOLUTION MEDICINES INC.’s own tally for this item (“Elect Director: Elizabeth McKee Anderson”): 107,146,109 for, 23,367,071 withheld, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 164,913,014 outstanding shares: 65% for, 14% withheld (79% of the company cast a for/withheld vote).

The 70 asset managers below cast 99.9% of the shares they voted on this item FOR (44,383,531 for, 62 against).

FOR 83%ABSTAIN 17%

FOR: 44,383,531 (83.2%)AGAINST: 62 (0.0%)ABSTAIN: 8,945,192 (16.8%)

Largest asset managers voting on “To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or ” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	22,232,107	0	For
BlackRock	6,608,389	0	For
Fidelity	5,792,108	1,400	For
T. Rowe Price	0	3,734,343	Abstain
State Street	2,349,129	3,240	For
JANUS INVESTMENT FUND	0	2,192,696	Abstain
JPMorgan	2,096,349	0	For
Charles Schwab	1,057,860	0	For
Dimensional	0	826,675	Abstain
Hartford	758,858	0	For
Columbia Threadneedle	708,697	0	For
MUTUAL FUND SERIES TRUST	650,826	0	For
Victory Capital	2,257	459,383	Abstain
Equitable	214,272	174,336	For
TIAA	363,923	0	For
AIG/SunAmerica	0	263,509	Abstain
QUANTITATIVE MASTER SERIES LLC	260,003	0	For
Bridge Builder Trust	34,475	186,843	Abstain
John Hancock	88,806	111,039	Abstain
Direxion Shares ETF Trust	0	183,868	Abstain
Voya	164,067	0	For
Northwestern Mutual	152,888	0	For
Lincoln Financial	135,547	5,214	For
Jackson National	0	120,029	Abstain
ALPS ETF Trust	0	115,256	Abstain

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

5. To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 148,105,275AGAINST: 9,895

REVOLUTION MEDICINES INC.’s own tally for this item (“Proposal 2 . The Company's stockholders ratified the appointment, by the audit committee of the Company's board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Comp”): 148,105,275 for, 9,895 against, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 164,913,014 outstanding shares: 90% for, 0.1% against (90% of the company cast a for/against vote).

The 70 asset managers below cast 100% of the shares they voted on this item FOR (53,317,724 for, 0 against).

FOR 99.9%

FOR: 53,317,724 (100.0%)ABSTAIN: 11,061 (0.0%)

Largest asset managers voting on “To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoope” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Vote
Vanguard	22,232,107	For
BlackRock	6,608,389	For
Fidelity	5,793,508	For
T. Rowe Price	3,734,343	For
State Street	2,352,369	For
JANUS INVESTMENT FUND	2,192,696	For
JPMorgan	2,096,349	For
Charles Schwab	1,057,860	For
Dimensional	826,675	For
Hartford	758,858	For
Columbia Threadneedle	708,697	For
MUTUAL FUND SERIES TRUST	650,826	For
Victory Capital	461,640	For
Equitable	388,608	For
TIAA	363,923	For
AIG/SunAmerica	263,509	For
QUANTITATIVE MASTER SERIES LLC	260,003	For
Bridge Builder Trust	221,318	For
John Hancock	199,845	For
Direxion Shares ETF Trust	183,868	For
Voya	164,067	For
Northwestern Mutual	152,888	For
Lincoln Financial	140,761	For
Jackson National	120,029	For
ALPS ETF Trust	115,256	For

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

6. To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Revolution Medicines special meeting to approve the Revolution Medicines share issuance proposal.

CORPORATE GOVERNANCE

Meeting held 2023-11-08; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

78% fund support · no official result

FOR 78%AGAINST 22%

The 63 asset managers below cast 78% of the shares they voted on this item FOR (28,344,891 for, 7,902,667 against).

FOR: 28,344,891 (77.9%)AGAINST: 7,902,667 (21.7%)ABSTAIN: 124,581 (0.3%)

Largest asset managers voting on “To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	15,320,068	0	0	For
T. Rowe Price	0	3,884,643	0	Against
BlackRock	3,596,886	0	0	For
Fidelity	576,453	1,847,742	0	Against
JPMorgan	2,202,536	0	0	For
State Street	0	1,895,188	0	Against
Dimensional	1,401,752	0	0	For
Charles Schwab	764,371	0	0	For
JANUS INVESTMENT FUND	714,722	0	0	For
Columbia Threadneedle	500,650	0	0	For
Hartford	492,599	0	0	For
MUTUAL FUND SERIES TRUST	361,000	0	0	For
Victory Capital	314,890	0	0	For
Equitable	162,009	20,148	113,520	For
TIAA	274,945	0	0	For
AIG/SunAmerica	256,626	0	0	For
QUANTITATIVE MASTER SERIES LLC	168,884	0	0	For
Brighthouse	63,148	68,556	11,061	Against
John Hancock	79,377	56,238	0	For
Northwestern Mutual	117,269	0	0	For
Lincoln Financial	28,333	82,400	0	Against
Direxion Shares ETF Trust	107,663	0	0	For
Jackson National	91,021	0	0	For
First Trust	86,234	0	0	For
MML SERIES INVESTMENT FUND	71,868	0	0	For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

7. To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRX, Inc., which is referred to as EQRX, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox

EXTRAORDINARY TRANSACTIONS

Meeting held 2023-11-08; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

81% fund support · no official result

FOR 81%AGAINST 19%

The 63 asset managers below cast 81% of the shares they voted on this item FOR (29,507,898 for, 6,750,721 against).

FOR: 29,507,898 (81.1%)AGAINST: 6,750,721 (18.6%)ABSTAIN: 113,520 (0.3%)

Largest asset managers voting on “To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into ” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	9,377,283	5,942,785	0	For
T. Rowe Price	3,884,643	0	0	For
BlackRock	3,596,886	0	0	For
Fidelity	2,424,195	0	0	For
JPMorgan	2,202,536	0	0	For
State Street	1,895,188	0	0	For
Dimensional	1,401,752	0	0	For
Charles Schwab	764,371	0	0	For
JANUS INVESTMENT FUND	714,722	0	0	For
Columbia Threadneedle	500,650	0	0	For
Hartford	0	492,599	0	Against
MUTUAL FUND SERIES TRUST	361,000	0	0	For
Victory Capital	312,928	1,962	0	For
Equitable	182,157	0	113,520	For
TIAA	274,945	0	0	For
AIG/SunAmerica	256,626	0	0	For
QUANTITATIVE MASTER SERIES LLC	168,884	0	0	For
Brighthouse	111,972	30,793	0	For
John Hancock	95,282	40,333	0	For
Northwestern Mutual	0	117,269	0	Against
Lincoln Financial	110,733	0	0	For
Direxion Shares ETF Trust	107,663	0	0	For
Jackson National	91,021	0	0	For
First Trust	86,234	0	0	For
MML SERIES INVESTMENT FUND	0	71,868	0	Against

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-06-20.

98% fund support · no official result

FOR 98%

The 4 asset managers below cast 98% of the shares they voted on this item FOR (2,934,131 for, 58,627 against).

FOR: 2,934,131 (98.0%)AGAINST: 58,627 (2.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Against	Vote
JPMorgan	2,764,061	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	169,821	0	For
Desjardins Global Asset Management Inc.	0	58,627	Against
TD ASSET MANAGEMENT INC	249	0	For

9. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION (SAY-ON-PAY&QUOT). &QUOT

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-06-20.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,675,757 for, 0 against).

FOR: 3,675,757 (100.0%)

Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DI” at REVOLUTION MEDICINES INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Boxer Capital, LLC	3,675,582	0	0	0	For
WIMMER ASSOCIATES 1, LLC	175	0	0	0	For

Largest REVOLUTION MEDICINES INC. shareholders voting in 2023-2024

Ranked by the number of REVOLUTION MEDICINES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 164,913,014 shares outstanding at the time of that meeting.

Top REVOLUTION MEDICINES INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	13.68%
2	New York Life	10.35%
3	Wellington	8.04%
4	BlackRock	6.81%
5	Fidelity	6.07%
6	T. Rowe Price	5.16%
7	State Street	4.40%
8	BVF INC/IL	3.63%
9	Nextech Invest Ltd.	3.49%
10	FARALLON CAPITAL MANAGEMENT LLC	3.08%

Reported REVOLUTION MEDICINES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

REVOLUTION MEDICINES INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.50%	13F
Entities affiliated with Wellington Management Group	9.02%	DEF14A
Wellington Management	8.92%	13F
FMR (Fidelity)	5.70%	13F
BlackRock	5.05%	13F
Thilo Schroeder, Ph.D.	3.93%	DEF14A
State Street	3.27%	13F
T. Rowe Price	2.92%	13F
Geode Capital	1.85%	13F
Alexis Borisy	1.59%	DEF14A

Percentages above are of 164,913,014 shares outstanding, as reported by REVOLUTION MEDICINES INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REVOLUTION MEDICINES INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At REVOLUTION MEDICINES INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held 2023-11-08 and 2024-06-20), 243 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,096 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. REVOLUTION MEDICINES INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — the reporting funds cast 99.2% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

REVOLUTION MEDICINES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.